NCT06959368View on ClinicalTrials.gov

Vonoprazan Evaluation Compared to Standard Triple Therapy in Helicobacter Pylori eRadication

PHASE4RecruitingINTERVENTIONAL
Enrollment

484

Participants

Timeline

Start Date

March 25, 2025

Primary Completion Date

March 25, 2026

Study Completion Date

March 25, 2026

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Vonoprazan 20mg, Esomeprazole 40 mg, Amoxicillin 1 g, Clarithromycin 500 mg

Participants will receive the respective drug regimens twice daily. The Vonoprazan triple therapy arm will administer Vonoprazan 20 mg, Amoxicillin 1 g, and Clarithromycin 500 mg twice daily. The Standard triple therapy arm will administer Esomeprazole 40 mg, Amoxicillin 1 g, and Clarithromycin 500 mg twice daily.

Trial Locations (1)

500082

RECRUITING

AIG hospitals, Hyderabad

All Listed Sponsors
lead

Asian Institute of Gastroenterology, India

OTHER